vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.

Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $75.5M, roughly 2.0× PUMA BIOTECHNOLOGY, INC.). On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-11.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 27.8%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

PBYI vs SHLS — Head-to-Head

Bigger by revenue
SHLS
SHLS
2.0× larger
SHLS
$148.3M
$75.5M
PBYI
Growing faster (revenue YoY)
SHLS
SHLS
+10.9% gap
SHLS
38.6%
27.7%
PBYI
More free cash flow
PBYI
PBYI
$25.6M more FCF
PBYI
$14.4M
$-11.3M
SHLS
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
27.8%
SHLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
SHLS
SHLS
Revenue
$75.5M
$148.3M
Net Profit
$8.1M
Gross Margin
69.3%
31.6%
Operating Margin
22.7%
11.7%
Net Margin
5.5%
Revenue YoY
27.7%
38.6%
Net Profit YoY
3.9%
EPS (diluted)
$0.26
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SHLS
SHLS
Q4 25
$75.5M
$148.3M
Q3 25
$54.5M
$135.8M
Q2 25
$52.4M
$110.8M
Q1 25
$46.0M
$80.4M
Q4 24
$59.1M
$107.0M
Q3 24
$80.5M
$102.2M
Q2 24
$47.1M
$99.2M
Q1 24
$43.8M
$90.8M
Net Profit
PBYI
PBYI
SHLS
SHLS
Q4 25
$8.1M
Q3 25
$8.8M
$11.9M
Q2 25
$5.9M
$13.9M
Q1 25
$3.0M
$-282.0K
Q4 24
$7.8M
Q3 24
$20.3M
$-267.0K
Q2 24
$-4.5M
$11.8M
Q1 24
$-4.8M
$4.8M
Gross Margin
PBYI
PBYI
SHLS
SHLS
Q4 25
69.3%
31.6%
Q3 25
77.7%
37.0%
Q2 25
76.5%
37.2%
Q1 25
77.1%
35.0%
Q4 24
76.4%
37.6%
Q3 24
63.9%
24.8%
Q2 24
77.4%
40.3%
Q1 24
75.5%
40.2%
Operating Margin
PBYI
PBYI
SHLS
SHLS
Q4 25
22.7%
11.7%
Q3 25
17.6%
13.7%
Q2 25
12.7%
14.4%
Q1 25
8.7%
5.4%
Q4 24
22.6%
15.4%
Q3 24
27.4%
4.4%
Q2 24
-4.6%
18.7%
Q1 24
-5.3%
12.8%
Net Margin
PBYI
PBYI
SHLS
SHLS
Q4 25
5.5%
Q3 25
16.2%
8.7%
Q2 25
11.2%
12.5%
Q1 25
6.5%
-0.4%
Q4 24
7.3%
Q3 24
25.2%
-0.3%
Q2 24
-9.6%
11.9%
Q1 24
-11.0%
5.3%
EPS (diluted)
PBYI
PBYI
SHLS
SHLS
Q4 25
$0.26
$0.05
Q3 25
$0.17
$0.07
Q2 25
$0.12
$0.08
Q1 25
$0.06
$0.00
Q4 24
$0.40
$0.04
Q3 24
$0.41
$0.00
Q2 24
$-0.09
$0.07
Q1 24
$-0.10
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SHLS
SHLS
Cash + ST InvestmentsLiquidity on hand
$97.5M
$7.3M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$600.0M
Total Assets
$216.3M
$904.1M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SHLS
SHLS
Q4 25
$97.5M
$7.3M
Q3 25
$94.4M
$8.6M
Q2 25
$96.0M
$4.7M
Q1 25
$93.2M
$35.6M
Q4 24
$101.0M
$23.5M
Q3 24
$96.7M
$11.1M
Q2 24
$96.8M
$3.2M
Q1 24
$107.2M
$15.2M
Total Debt
PBYI
PBYI
SHLS
SHLS
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
$141.8M
Q4 24
$68.0M
$141.8M
Q3 24
$79.3M
$141.8M
Q2 24
$90.7M
$146.8M
Q1 24
$102.0M
$168.8M
Stockholders' Equity
PBYI
PBYI
SHLS
SHLS
Q4 25
$130.3M
$600.0M
Q3 25
$115.3M
$589.6M
Q2 25
$104.7M
$575.4M
Q1 25
$97.1M
$558.9M
Q4 24
$92.1M
$556.8M
Q3 24
$71.1M
$545.2M
Q2 24
$48.5M
$544.6M
Q1 24
$51.0M
$554.0M
Total Assets
PBYI
PBYI
SHLS
SHLS
Q4 25
$216.3M
$904.1M
Q3 25
$202.9M
$851.8M
Q2 25
$194.9M
$795.0M
Q1 25
$196.2M
$788.4M
Q4 24
$213.3M
$793.1M
Q3 24
$220.7M
$801.3M
Q2 24
$205.0M
$788.4M
Q1 24
$214.1M
$825.3M
Debt / Equity
PBYI
PBYI
SHLS
SHLS
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
0.25×
Q4 24
0.74×
0.25×
Q3 24
1.12×
0.26×
Q2 24
1.87×
0.27×
Q1 24
2.00×
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SHLS
SHLS
Operating Cash FlowLast quarter
$14.4M
$-4.1M
Free Cash FlowOCF − Capex
$14.4M
$-11.3M
FCF MarginFCF / Revenue
19.1%
-7.6%
Capex IntensityCapex / Revenue
0.0%
4.8%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SHLS
SHLS
Q4 25
$14.4M
$-4.1M
Q3 25
$9.7M
$19.4M
Q2 25
$14.1M
$-13.8M
Q1 25
$3.6M
$15.6M
Q4 24
$15.6M
$14.0M
Q3 24
$11.0M
$15.7M
Q2 24
$1.0M
$37.8M
Q1 24
$11.2M
$12.9M
Free Cash Flow
PBYI
PBYI
SHLS
SHLS
Q4 25
$14.4M
$-11.3M
Q3 25
$9.7M
$9.0M
Q2 25
$14.1M
$-26.0M
Q1 25
$3.6M
$12.3M
Q4 24
$15.6M
$12.5M
Q3 24
$11.0M
$13.3M
Q2 24
$1.0M
$35.8M
Q1 24
$10.4M
FCF Margin
PBYI
PBYI
SHLS
SHLS
Q4 25
19.1%
-7.6%
Q3 25
17.7%
6.6%
Q2 25
26.8%
-23.5%
Q1 25
7.7%
15.4%
Q4 24
26.4%
11.6%
Q3 24
13.7%
13.0%
Q2 24
2.1%
36.1%
Q1 24
11.4%
Capex Intensity
PBYI
PBYI
SHLS
SHLS
Q4 25
0.0%
4.8%
Q3 25
0.0%
7.7%
Q2 25
0.0%
11.0%
Q1 25
0.1%
4.0%
Q4 24
0.0%
1.4%
Q3 24
0.0%
2.3%
Q2 24
0.0%
2.0%
Q1 24
0.0%
2.7%
Cash Conversion
PBYI
PBYI
SHLS
SHLS
Q4 25
-0.50×
Q3 25
1.10×
1.63×
Q2 25
2.41×
-1.00×
Q1 25
1.21×
Q4 24
1.79×
Q3 24
0.54×
Q2 24
3.21×
Q1 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

Related Comparisons